JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adler, R. H.
Right arrow Articles by Levinsky, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adler, R. H.
Right arrow Articles by Levinsky, L.

The Journal of Thoracic and Cardiovascular Surgery, Vol 76, 859-864, Copyright © 1978 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Persistent chylothorax. Treatment by talc pleurodesis

RH Adler and L Levinsky

Two patients with persistent chylothorax resistant to therapy by special diet, thoracenteses, and tube thoracostomy drainage were successfully treated by talc pleurodesis. In one patient with advanced lymphosarcoma involving pleura and mediastinal nodes, the chylothorax was managed by open thoracotomy and talc powder. The other patient developed chylothorax following resection of a thoracic aortic aneurysm. She was successfully treated by talc suspension introduced through a thoracostomy tube. Pleurodesis with talc should be considered only when the chylothorax persists after an adequate period of medical treatment and pleural decompression. Intrapleural instillation of talc through a thoracostomy tube should be successful if the chylothorax can be evacuated and the underlying lung fully expanded.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
S. A Al-Zubairy and A. S Al-Jazairi
Octreotide as a Therapeutic Option for Management of Chylothorax
Ann. Pharmacother., May 1, 2003; 37(5): 679 - 682.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
V. Jitendra, D B. Reddy, and M P N. Kumar
Management of Post-Fontan Chylothorax With Non-Valved Silastic Conduit
Asian Cardiovasc Thorac Ann, September 1, 2001; 9(3): 243 - 245.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Glazer, N. Berkman, J. S. Lafair, and M. R. Kramer
Successful Talc Slurry Pleurodesis in Patients With Nonmalignant Pleural Effusion
Chest, May 1, 2000; 117(5): 1404 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J.-M. Collard, P.-F. Laterre, F. Boemer, M. Reynaert, and R. Ponlot
Conservative Treatment of Postsurgical Lymphatic Leaks With Somatostatin-14
Chest, March 1, 2000; 117(3): 902 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Shirai, J. Amano, and K. Takabe
Thoracoscopic diagnosis and treatment of chylothorax after pneumonectomy
Ann. Thorac. Surg., August 1, 1991; 52(2): 306 - 307.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. C. Murphy, B. M. Newman, and B. M. Rodgers
Pleuroperitoneal shunts in the management of persistent chylothorax
Ann. Thorac. Surg., August 1, 1989; 48(2): 195 - 200.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. Weissberg and M. Kaufman
The Use of Talc for Pleurodesis in the Treatment of Resistant Empyema
Ann. Thorac. Surg., February 1, 1986; 41(2): 143 - 145.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1978 by The American Association for Thoracic Surgery.